Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Industry News

Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure

June 13, 2016

News Daily News

Europeans Issue Guidance on Direct Discharge of Acute Heart Failure Patients From ED

Todd Neale

February 23, 2016

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Industry News

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure

June 02, 2015

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Conference News ESC 2012

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

Yael L. Maxwell

August 29, 2012

Advertisement

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure

Europeans Issue Guidance on Direct Discharge of Acute Heart Failure Patients From ED

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content